Author
Listed:
- Pradeep Bist
(Program in Emerging Infectious Diseases, Duke-NUS Medical School)
- Wan Shoo Cheong
(Program in Emerging Infectious Diseases, Duke-NUS Medical School)
- Aylwin Ng
(Gastrointestinal Unit, Center for Computational and Integrative Biology, Massachusetts General Hospital, Harvard Medical School
Broad Institute of Harvard and MIT)
- Neha Dikshit
(Program in Emerging Infectious Diseases, Duke-NUS Medical School)
- Bae-Hoon Kim
(HHMI, Yale Systems Biology Institute, Yale University School of Medicine)
- Niyas Kudukkil Pulloor
(Program in Emerging Infectious Diseases, Duke-NUS Medical School)
- Hanif Javanmard Khameneh
(Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR))
- Matija Hedl
(Yale University School of Medicine)
- Avinash R. Shenoy
(HHMI, Yale Systems Biology Institute, Yale University School of Medicine
Medical Research Council Centre for Molecular Bacteriology & Infection)
- Vanniarajan Balamuralidhar
(Program in Emerging Infectious Diseases, Duke-NUS Medical School)
- Najib Bin Abdul Malik
(Program in Emerging Infectious Diseases, Duke-NUS Medical School)
- Michelle Hong
(Program in Emerging Infectious Diseases, Duke-NUS Medical School)
- Albert Neutzner
(University Hospital Basel)
- Keh-Chuang Chin
(Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR)
Yong Loo Lin School of Medicine
Institute of Molecular and Cell Biology, A*STAR)
- Koichi S. Kobayashi
(Texas A&M Health Science Centre)
- Antonio Bertoletti
(Program in Emerging Infectious Diseases, Duke-NUS Medical School)
- Alessandra Mortellaro
(Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR))
- Clara Abraham
(Yale University School of Medicine)
- John D. MacMicking
(HHMI, Yale Systems Biology Institute, Yale University School of Medicine)
- Ramnik J. Xavier
(Gastrointestinal Unit, Center for Computational and Integrative Biology, Massachusetts General Hospital, Harvard Medical School
Broad Institute of Harvard and MIT)
- Bindu Sukumaran
(Program in Emerging Infectious Diseases, Duke-NUS Medical School)
Abstract
Optimal regulation of the innate immune receptor nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is essential for controlling bacterial infections and inflammatory disorders. Chronic NOD2 stimulation induces non-responsiveness to restimulation, termed NOD2-induced tolerance. Although the levels of the NOD2 adaptor, RIP2, are reported to regulate both acute and chronic NOD2 signalling, how RIP2 levels are modulated is unclear. Here we show that ZNRF4 induces K48-linked ubiquitination of RIP2 and promotes RIP2 degradation. A fraction of RIP2 localizes to the endoplasmic reticulum (ER), where it interacts with ZNRF4 under either unstimulated and muramyl dipeptide-stimulated conditions. Znrf4 knockdown monocytes have sustained nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation, and Znrf4 knockdown mice have reduced NOD2-induced tolerance and more effective control of Listeria monocytogenes infection. Our results thus demonstrate E3-ubiquitin ligase ZNRF4-mediated RIP2 degradation as a negative regulatory mechanism of NOD2-induced NF-κB, cytokine and anti-bacterial responses in vitro and in vivo, and identify a ZNRF4-RIP2 axis of fine-tuning NOD2 signalling to promote protective host immunity.
Suggested Citation
Pradeep Bist & Wan Shoo Cheong & Aylwin Ng & Neha Dikshit & Bae-Hoon Kim & Niyas Kudukkil Pulloor & Hanif Javanmard Khameneh & Matija Hedl & Avinash R. Shenoy & Vanniarajan Balamuralidhar & Najib Bin , 2017.
"E3 Ubiquitin ligase ZNRF4 negatively regulates NOD2 signalling and induces tolerance to MDP,"
Nature Communications, Nature, vol. 8(1), pages 1-16, August.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15865
DOI: 10.1038/ncomms15865
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15865. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.